Antitumor Effect of 131I-Labeled Anti-VEGFR2 Targeted Mesoporous Silica Nanoparticles in Anaplastic Thyroid Cancer
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1556-276X
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Antitumor Effect of 131I-Labeled Anti-VEGFR2 Targeted Mesoporous Silica Nanoparticles in Anaplastic Thyroid Cancer ; volume:14 ; number:1 ; day:14 ; month:3 ; year:2019 ; pages:1-11 ; date:12.2019
Nanoscale research letters ; 14, Heft 1 (14.3.2019), 1-11, 12.2019
- Urheber
-
Zhang, Ruiguo
Zhang, Yueqian
Tan, Jian
Wang, Hanjie
Zhang, Guizhi
Li, Ning
Meng, Zhaowei
Zhang, Fuhai
Chang, Jin
Wang, Renfei
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s11671-019-2924-z
- URN
-
urn:nbn:de:101:1-2019040716424339952158
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:03 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Zhang, Ruiguo
- Zhang, Yueqian
- Tan, Jian
- Wang, Hanjie
- Zhang, Guizhi
- Li, Ning
- Meng, Zhaowei
- Zhang, Fuhai
- Chang, Jin
- Wang, Renfei
- SpringerLink (Online service)
Ähnliche Objekte (12)
Radioimmunotherapy study of 131I-labeled Atezolizumab in preclinical models of colorectal cancer
Enhanced antitumor immune responses via a new agent [131I]-labeled dual-target immunosuppressant
In vitro cytotoxicity of 131I-labeled monoclonal antibody OC125 F(ab')2 on epithelial ovarian cancer cell lines
Consequences of VEGFR2 ablation during development
Targeted radioimmunotherapy with the iodine-131-labeled caerin 1.1 peptide for human anaplastic thyroid cancer in nude mice
Comprehensive Analysis of VEGFR2 Expression in HPV-Positive and -Negative OPSCC Reveals Differing VEGFR2 Expression Patterns
124I-Radiojodtest : Vergleich des prätherapeutischen 124I- und 131I-Uptakes mit dem intratherapeutischen 131I-Uptake bei benignen Schilddrüsenerkrankungen
Kernresonanz an orientiertem 60Co [Co], 131I [I], 183Re [Re], 183Os [Os] und Relaxationsmessungen an 131I [I] in Eisen
Interventional therapy for human breast cancer in nude mice with 131I gelatin microspheres (131I-GMSs) following intratumoral injection
Cutaneous Involvement of Systemic Anaplastic Lymphoma Kinase-Positive Anaplastic Large Cell Lymphoma
VEGFR2 function during neuronal development and synaptic plasticity
Sec14l3 potentiates VEGFR2 signaling to regulate zebrafish vasculogenesis
Radioimmunotherapy study of 131I-labeled Atezolizumab in preclinical models of colorectal cancer
Enhanced antitumor immune responses via a new agent [131I]-labeled dual-target immunosuppressant
In vitro cytotoxicity of 131I-labeled monoclonal antibody OC125 F(ab')2 on epithelial ovarian cancer cell lines
Consequences of VEGFR2 ablation during development
Targeted radioimmunotherapy with the iodine-131-labeled caerin 1.1 peptide for human anaplastic thyroid cancer in nude mice
Comprehensive Analysis of VEGFR2 Expression in HPV-Positive and -Negative OPSCC Reveals Differing VEGFR2 Expression Patterns
124I-Radiojodtest : Vergleich des prätherapeutischen 124I- und 131I-Uptakes mit dem intratherapeutischen 131I-Uptake bei benignen Schilddrüsenerkrankungen
Kernresonanz an orientiertem 60Co [Co], 131I [I], 183Re [Re], 183Os [Os] und Relaxationsmessungen an 131I [I] in Eisen
Interventional therapy for human breast cancer in nude mice with 131I gelatin microspheres (131I-GMSs) following intratumoral injection
Cutaneous Involvement of Systemic Anaplastic Lymphoma Kinase-Positive Anaplastic Large Cell Lymphoma
VEGFR2 function during neuronal development and synaptic plasticity
Sec14l3 potentiates VEGFR2 signaling to regulate zebrafish vasculogenesis
Radioimmunotherapy study of 131I-labeled Atezolizumab in preclinical models of colorectal cancer
Enhanced antitumor immune responses via a new agent [131I]-labeled dual-target immunosuppressant
In vitro cytotoxicity of 131I-labeled monoclonal antibody OC125 F(ab')2 on epithelial ovarian cancer cell lines
Consequences of VEGFR2 ablation during development
Targeted radioimmunotherapy with the iodine-131-labeled caerin 1.1 peptide for human anaplastic thyroid cancer in nude mice
Comprehensive Analysis of VEGFR2 Expression in HPV-Positive and -Negative OPSCC Reveals Differing VEGFR2 Expression Patterns
124I-Radiojodtest : Vergleich des prätherapeutischen 124I- und 131I-Uptakes mit dem intratherapeutischen 131I-Uptake bei benignen Schilddrüsenerkrankungen
Kernresonanz an orientiertem 60Co [Co], 131I [I], 183Re [Re], 183Os [Os] und Relaxationsmessungen an 131I [I] in Eisen
Interventional therapy for human breast cancer in nude mice with 131I gelatin microspheres (131I-GMSs) following intratumoral injection
Cutaneous Involvement of Systemic Anaplastic Lymphoma Kinase-Positive Anaplastic Large Cell Lymphoma
VEGFR2 function during neuronal development and synaptic plasticity